The findings of the current study suggest that even if postpartum depression could be prevented and/or treated adequately, there would still remain a small percentage of women who would remain chronically depressed after childbirth.
Results from a recent clinical trial indicate a considerable number of depressed women do not get diagnosed during the first postpartum year of their lives. The potential for early detection and effective treatment may be important in decreasing the depression burden in the community.
Signs of depression can appear anytime in the postpartum and could not be identified by mothers. The severity and distress of these signs were greater in patients with depression and lesser in patients without depression.
This chapter concludes with specific guidelines for postpartum depression. A comprehensive assessment for this disease is recommended from the first postpartum visit for all women and an immediate referral to the appropriate provider is advised for any women who have persistent symptoms or are not appropriately managing their pain.
This condition occurs during or after delivery and after delivery to women. During this time women experience symptoms like fear or sadness that may last for several days. Symptoms may include a sense of self-worthlessness or hopelessness and thoughts of suicide or harming oneself or others. Symptoms may vary depending on the baby's birth status and are more common in the first two weeks after delivery. After this initial period of sadness and fear, postpartum depression may be short lived or, if serious, it may not go away but can manifest as depressive features or symptoms.
The workshop was well received, but it had minimal impact on participants. The workshop may be more beneficial in improving knowledge and skills than impacting outcomes. The study will be repeated in an enhanced format to assess how best a workshop can impact outcomes.
A recent systematic review showed that, to a limited extent, there is evidence of effectiveness for postpartum depression, especially when delivered as part of the standard of care. However, there is insufficient evidence to recommend its routine use. Also, there is limited evidence available regarding antidepressant use or other interventions for postpartum depression.
The 1-day CBT workshop was well regarded by medical staff, trainees and participants. This demonstrates that the workshops may be a promising treatment modality for the medical health care setting.
A CBT-based intervention programme provided by a counsellor, tailored to individual requirements, is effective in the treatment of postpartum depression. The intervention programme produced significant improvements in patient QoL. A clinical trial is required to confirm the extent and duration of these benefits and to investigate the cost-effectiveness of the programme.
Clinicians should consider trial entry or retention for those who are depressed, either postpartum or not. For those who are satisfied with their care, they may opt to continue treatment regardless of trial entry or retention.
These preliminary results, limited by small sample size and short treatment duration, suggest that CBT-based workshops may be associated with an improvement in self-rated psychological wellbeing.